Skip to main navigation
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact

Event Details

Investor Menu

IR Nav

  • Overview
  • News & Events
    News Releases Events Publications
  • Financials
    SEC Filings Quarterly Results
  • Stock
    Stock Performance Analyst Coverage
  • Corporate Governance
    Governance Documents Leadership Board of Directors Committee Composition
  • Resources
    Investor FAQs Contact Us Email Alerts

73rd Annual Meeting of Japanese Society of Allergology

Oct 18 - Oct 20, 2024

  • Presentation: Efficacy and safety of oral deucrictibant IR capsule in HAE: RAPIDe-3 phase 3 trial design
    Speaker: Prof. Michihiro Hide, M.D., Ph.D.
    Format: Oral Presentation
    Date, Time: Sunday, Oct. 20, 13:30-14:45 JST (12:30 -1:45 a.m. EDT)
     

Supporting Materials

Efficacy and Safety of Oral Deucrictibant Immediate-Release Capsule in Hereditary Angioedema: RAPIDe-3 Phase 3 Clinical Trial Design 637.6 KB
Pharvaris N.V.

©2026 Pharvaris N.V. © All Rights Reserved

Menu
  • Privacy Policy
  • Clinical Trial Privacy Notice
  • Global Privacy Laws
  • Terms of Use
CONTACT US
FOLLOW US